跳至主要内容
临床试验/NCT04303390
NCT04303390已完成4 期

24 Versus 48 Hours of First Generation or Second Generation Cephalosporin as Prophylaxis to Reduce Surgical Site Infection in Adult Cardiac Surgery Patients: a Randomized Controlled Trial

Saud Al Babtain Cardiac Center1 个研究点 分布在 1 个国家目标入组 568 人开始时间: 2018年2月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
568
试验地点
1
主要终点
surgical site infection rate is less with 48 hours rather than 24 hours

研究概览

简要总结

A randomized control trial studying the effect of prophylactic antibiotics to reduce surgical site infections following cardiac surgery in adults using 1st generation cephalosporin (Cefazolin) or 2nd generation cephalosporin (Cefuroxime).

详细描述

A prospective randomized controlled patient blinded study with 2x2 factional design. It aims to study optimal duration of antibiotic to reduce surgical site infections following cardiac surgery in adults 24 or 48 hours using 1st generation cephalosporin (Cefazolin) or 2nd generation cephalosporin (Cefuroxime). Patients shall remain on either medicines for 24 or 48 hours. The primary endpoints of the study are:(1) 48 hours antibiotic prophylaxis is superior to 24 hours in adult cardiac surgery (2) Cefuroxime is superior to Cafazolin as a prophylactic antibiotic in adult cardiac surgery. Secondary endpoints include; organisms causing surgical site infections, length of hospital and ICU stay, and worsening in renal function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to provide informed consent
  • Planned to undergo a cardiac surgical procedure

排除标准

  • Patients on antibiotics on the day of surgery or those who received any within 7 days for any reason
  • Patients taken to operating room as salvage
  • Patients who are allergic to either cefuroxime or cefazolin
  • Patients for LVAD or ECMO
  • Patients who are known MRSA carriers
  • Patients receiving steroid therapy

研究组 & 干预措施

24 hour Cefuroxime arm

Active Comparator

25% of the entire study participants are assigned to 24 hours and second generation cephalosporin

干预措施: 24 hours (Other)

24 hour Cefuroxime arm

Active Comparator

25% of the entire study participants are assigned to 24 hours and second generation cephalosporin

干预措施: Cefuroxime (Drug)

24 hour Cefazolin arm

Active Comparator

25% of the entire study participants are assigned to 24 hours and first generation cephalosporin

干预措施: Cefazolin (Drug)

24 hour Cefazolin arm

Active Comparator

25% of the entire study participants are assigned to 24 hours and first generation cephalosporin

干预措施: 24 hours (Other)

48 hour Cefuroxime arm

Active Comparator

25% of the entire study participants are assigned to 48 hours and second generation cephalosporin

干预措施: Cefuroxime (Drug)

48 hour Cefuroxime arm

Active Comparator

25% of the entire study participants are assigned to 48 hours and second generation cephalosporin

干预措施: 48 hours (Other)

48 hour Cefazolin arm

Active Comparator

25% of the entire study participants are assigned to 48 hours and first generation cephalosporin

干预措施: Cefazolin (Drug)

48 hour Cefazolin arm

Active Comparator

25% of the entire study participants are assigned to 48 hours and first generation cephalosporin

干预措施: 48 hours (Other)

结局指标

主要结局

surgical site infection rate is less with 48 hours rather than 24 hours

时间窗: within 3 months from date of surgery

That Longer duration of prophylaxis is better than shorter duration

surgical site infection rate is less with Cefuroxime than Cefazolin

时间窗: within 3 months from date of surgery

that Second Generation Cefalosporin is superior to first generation

次要结局

  • Length of ICU Stay will be shorter in the group assigned to 48 hours of cefuroxime(within 3 months from date of surgery)
  • Length of actual Hospital Stay in the group assigned to 48 hours of cefuroxime(within 3 months from date of surgery)
  • rate of infection with a specific organism following each of the antibiotics used(within 3 months from date of surgery)
  • change from baseline of serum creatinine for each antibiotic used(within 3 months from date of surgery)

研究者

发起方
Saud Al Babtain Cardiac Center
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验